Arcutis Biotherapeutics 주식 (NASDAQ: ARQT)

에 대한 최신 뉴스 Arcutis Biotherapeutics (NASDAQ:ARQT) 주식

ARCUTIS BIOTHERAPEUTICS INC

Arcutis Biotherapeutics

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Lucid EV. Photo by Around the World Photos on Shutterstock

Equities

Mid Cap

News

Movers

Tech

ARQT

CELH

CPRX

DGNX

GLNG

LCID

SBSW

STNE

지난 일주일 동안 가장 실적이 좋았던 중형주 10개 종목은 다음과 같다. 디지넥스, 넥스트데케이드, 셀시우스, 시그넷 주얼러스, 뉴 포트리스, 밀로즈, 아커티스, 루시드, 캐털리스트, 스톤코

셀시우스·루시드·시그넷 등 지난주 급등한 중형주 10종목 (3월 17일~21일)

Arcutis Biotherapeutics, Inc. - Common stock

Arcutis Biotherapeutics Inc

CLSA analyst Max Hopkins maintains NuScale Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) with a Outperform and raises the price target from $31 to $41.

Price Target

Analyst Ratings

CLSA Maintains Outperform on NuScale Power, Raises Price Target to $41

WIIM

CDT stock has given up its prior loss. Conduit Pharmaceuticals shares were trading lower after the company announced it received approval to transfer its listing from the Nasdaq Stock Market to the Nasdaq Capital Market

Retailer DICK's Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) could provide more details of <a href="https://www.benzinga.com/news/earnings/25/05/45435748/dicks-sporting-goods-to-acquire-foot-locker-at-66-premium">its planned acquisition</a> of Foot Locker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) when the company reports first-quarter financial results before<a href="https://www.benzinga.com/earnings"> market open Wednesday.</a>
Here are the analyst estimates, what analysts are saying after the acquisition was announced and key items to watch.
Earning Estimates: Analysts expect Dick's Sporting Goods to report first-quarter revenue of $3.59 billion, up from $3.02 billion in last year's first quarter, according to data<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0527"> from Benzinga Pro.</a>
The company has beaten analyst estimates for revenue in six straight quarters and in nine of the past 10 quarters overall.
Analysts expect the company to report first-quarter earnings per share of $4.34, up from $3.30 in last year's first quarter. The company has beaten analyst estimates for earnings per share in six straight quarters and in nine of the past 10 quarters overall.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/05/45585696/how-to-earn-500-a-month-from-dicks-sporting-goods-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Dick&#8217;s Sporting Goods Stock Ahead Of Q1 Earnings</a>
What Analysts Are Saying: Analysts lowered their price target on Dick's Sporting Goods stock after the Foot Locker <a href="https://www.benzinga.com/25/05/45476123/analyst-sees-long-term-gain-for-dicks-with-foot-locker-despite-investor-skepticism">acquisition was announced.</a>
Telsey analyst Joseph Feldman said the retailer could see near-term pressure as investors decipher the deal rationale and execution risks.
Feldman maintained an Outperform rating, while lowering the price target from $250 to $220.
The analyst said investors appear skeptical of the deal, with Dick's already having a strong presence in the U.S. sporting goods sector.
Feldman said Foot Locker is a mall-based retailer that has structural challenges and is heavily reliant on Nike Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), which makes up around 60% of sales.
While Feldman is cautious in the short term, the analyst sees the potential to unlock value with the acquisition and create a more dominant retailer in the sporting goods sector.
Here are other recent<a href="https://www.benzinga.com/quote/DKS/analyst-ratings"> analyst ratings on</a> Dick's Sporting Goods and their price targets:
<ul class="wp-block-list">
<li>DA Davidson: Maintained Buy rating with $273 price target</li>
<li>Loop Capital: Maintained Hold rating, lowered price target from $195 to $180</li>
<li>Baird: Maintained Neutral rating, lowered price target from $230 to $185</li>
<li>Barclays: Maintained Overweight rating, lowered price target from $223 to $217</li>
</ul>
Key Items to Watch: Along with the Foot Locker acquisition being the talk of the town, the other big topic analyst and investors will likely be watching will be tariffs.
Tariffs have taken center stage for many companies when they report financial results and share updated guidance, especially those in the retail sector, like Dick's Sporting Goods.
The company will likely highlight the impact tariffs could have on upcoming quarters and what steps are being taken to mitigate risk.
The first-quarter results will be important as they come after a <a href="https://www.benzinga.com/25/03/44246625/dicks-sporting-beats-q4-earnings-stock-falls-amid-soft-outlook">strong fourth quarter </a>that saw the company's largest sales quarter in company history and strong comparable sales growth of 6.4%.
Dick's also announced a new five-year share buyback program of up to $3 billion back in March. Details of this buyback or an increased commitment level could create new optimism and offset concerns from the acquisition and tariffs.
Another area to watch could be Dick's increased interest in trading cards, which comes after winning a $1.1 million auction for a rare one-of-one Paul Skenes baseball card. The company recently displayed the card at its House of Sport store in Pennsylvania, as reported by <a href="https://www.cllct.com/sports-collectibles/sports-cards/dick-s-sporting-goods-launches-paul-skenes-debut-patch-display-in-new-collectors-shop">Cllct</a>.
The company has plans to boost its trading cards and memorabilia selections at House of Sport stores and could use this card as a centerpiece to travel around to other locations. <a href="https://www.benzinga.com/go/public-com-bonds" target="_blank" rel="noreferrer noopener"></a>
DKS Price Action: Dick's Sporting Goods stock is up 3.92% to $173.81 on Tuesday versus a 52-week trading range of $166.37 to $254.60. The stock is down about 24% year-to-date in 2025.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/05/45477478/whats-next-for-foot-locker-analyst-says-dicks-deal-is-timely">What&#8217;s Next For Foot Locker? Analyst Says Dick&#8217;s Deal Is Timely</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Earnings

Previews

Trading Ideas

Dick's Sporting Goods Q1 Preview: All Eyes On Foot Locker Deal, Tariff Impact

Baird analyst Shrenik Kothari maintains Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) with a Neutral and raises the price target from $112 to $115.

FTNT

Baird Maintains Neutral on Fortinet, Raises Price Target to $115

CLSA analyst Max Hopkins maintains Oklo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) with a Outperform and raises the price target from $50 to $74.

OKLO

CLSA Maintains Outperform on Oklo, Raises Price Target to $74

<h3>Gainers</h3>
<ul>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) shares increased by 459.7% to $37.61 during Tuesday's regular session. The market value of their outstanding shares is at $24.8 million. </li>
<li>LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) stock moved upwards by 118.81% to $2.21. The market value of their outstanding shares is at $449.8 million. </li>
<li>E-Home Household Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) stock moved upwards by 52.67% to $0.15. The market value of their outstanding shares is at $1.3 million. </li>
<li>iRobot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRBT#NASDAQ">IRBT</a>) shares rose 43.06% to $3.69. The market value of their outstanding shares is at $113.0 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) stock rose 26.62% to $2.14. The company's market cap stands at $612.4 million. </li>
<li>Vision Marine Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) stock increased by 18.82% to $7.6. The market value of their outstanding shares is at $8.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>QVC Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QVCGP#NASDAQ">QVCGP</a>) shares declined by 50.5% to $7.63 during Tuesday's regular session. </li>
<li>Jeffs Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) stock declined by 28.15% to $0.55. The market value of their outstanding shares is at $2.1 million. </li>
<li>Nova Lifestyle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVFY#NASDAQ">NVFY</a>) stock decreased by 18.69% to $1.2. The market value of their outstanding shares is at $16.4 million. </li>
<li>Champion Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKY#NYSE">SKY</a>) stock decreased by 16.03% to $70.76. The market value of their outstanding shares is at $4.0 billion. As per the press release, Q4 earnings came out today. </li>
<li>PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) stock decreased by 15.55% to $100.71. The company's market cap stands at $142.9 billion. As per the press release, Q1 earnings came out today. </li>
<li>Netclass Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) shares declined by 14.42% to $3.77. The company's market cap stands at $67.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IRBT

JFBR

LVWR

NTCL

NVFY

NWTN

Citigourp Global Markets 2% Protected Notes Linked To The Djia

QVCGP

SBET

VMAR

12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>SCWorx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WORX#NASDAQ">WORX</a>) shares rose 60.0% to $0.64 during Tuesday's regular session. The market value of their outstanding shares is at $2.3 million. </li>
<li>Forte Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBRX#NASDAQ">FBRX</a>) stock rose 40.28% to $11.91. The market value of their outstanding shares is at $78.4 million. </li>
<li>Tonix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) stock rose 29.08% to $37.34. The company's market cap stands at $273.5 million. </li>
<li>Anteris Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVR#NASDAQ">AVR</a>) stock increased by 27.19% to $4.63. The company's market cap stands at $166.4 million. </li>
<li>Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) shares moved upwards by 24.24% to $0.93. The company's market cap stands at $111.5 million. </li>
<li>Inotiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>) shares rose 24.05% to $2.63. The market value of their outstanding shares is at $90.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) shares decreased by 61.9% to $2.39 during Tuesday's regular session. The company's market cap stands at $257.2 million. </li>
<li>NeuroPace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) shares declined by 34.0% to $11.67. The company's market cap stands at $382.7 million. </li>
<li>Prothena Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTA#NASDAQ">PRTA</a>) stock fell 30.95% to $4.54. The company's market cap stands at $244.5 million. </li>
<li>Savara (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRA#NASDAQ">SVRA</a>) stock decreased by 30.64% to $1.97. The market value of their outstanding shares is at $340.4 million. </li>
<li>EXoZymes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXOZ#NASDAQ">EXOZ</a>) shares declined by 26.31% to $10.98. The market value of their outstanding shares is at $91.8 million. </li>
<li>RAPT Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) stock fell 20.01% to $0.98. The market value of their outstanding shares is at $130.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EXOZ

FBRX

IVVD

NOTV

NPCE

PRTA

RAPT

RCKT

SVRA

TNXP

WORX

12 Health Care Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Lavoro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVRO#NASDAQ">LVRO</a>) stock rose 74.6% to $4.19 during Tuesday's regular session. The market value of their outstanding shares is at $488.5 million. </li>
<li>OFA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFAL#NASDAQ">OFAL</a>) shares increased by 27.34% to $6.1. The market value of their outstanding shares is at $81.5 million. </li>
<li>Roma Green Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROMA#NASDAQ">ROMA</a>) shares rose 26.48% to $2.91. The market value of their outstanding shares is at $45.2 million. </li>
<li>Innovate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VATE#NYSE">VATE</a>) stock increased by 25.79% to $7.95. The market value of their outstanding shares is at $105.6 million. </li>
<li>Kelly Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KELYB#NASDAQ">KELYB</a>) shares increased by 20.7% to $13.7. The market value of their outstanding shares is at $477.9 million. </li>
<li>Captivision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPT#NASDAQ">CAPT</a>) shares moved upwards by 20.64% to $0.55. The company's market cap stands at $17.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Clean Energy Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETY#NASDAQ">CETY</a>) stock declined by 25.5% to $0.29 during Tuesday's regular session. The company's market cap stands at $17.3 million. </li>
<li>Jayud Global Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) shares declined by 15.73% to $0.22. The company's market cap stands at $20.2 million. </li>
<li>Webus International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETO#NASDAQ">WETO</a>) stock decreased by 14.95% to $1.65. The market value of their outstanding shares is at $36.3 million. </li>
<li>Skyline Builders Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKBL#NASDAQ">SKBL</a>) shares declined by 13.42% to $9.1. The company's market cap stands at $275.0 million. </li>
<li>Northann (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NCL#AMEX">NCL</a>) stock decreased by 12.52% to $0.83. The company's market cap stands at $46.2 million. </li>
<li>Eos Energy Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) stock decreased by 11.6% to $5.64. The market value of their outstanding shares is at $1.2 billion. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CAPT

CETY

EOSE

KELYB

LVRO

Nuveen Insured California Premium Fund Ii

OFAL

ROMA

SKBL

VATE

WETO

12 Industrials Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Navitas Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) stock moved upwards by 41.0% to $6.22 during Tuesday's regular session. The market value of their outstanding shares is at $1.1 billion. </li>
<li>E2open Parent Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) shares rose 25.09% to $3.21. The company's market cap stands at $996.6 million. </li>
<li>BTCS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCS#NASDAQ">BTCS</a>) shares rose 24.3% to $3.56. The company's market cap stands at $74.9 million. </li>
<li>BigBear.ai Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) stock moved upwards by 21.52% to $4.42. The company's market cap stands at $1.2 billion. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) stock rose 18.8% to $0.75. The company's market cap stands at $2.7 million. </li>
<li>Vuzix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VUZI#NASDAQ">VUZI</a>) stock increased by 16.46% to $2.83. The market value of their outstanding shares is at $215.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) stock declined by 24.6% to $0.87 during Tuesday's regular session. The company's market cap stands at $22.3 million. </li>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares declined by 16.28% to $1.55. The market value of their outstanding shares is at $15.4 million. </li>
<li>Mercurity Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) stock fell 15.26% to $3.61. The market value of their outstanding shares is at $229.9 million. </li>
<li>Red Cat Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) stock fell 14.45% to $5.83. The company's market cap stands at $530.4 million. </li>
<li>CISO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) shares fell 10.89% to $1.1. The market value of their outstanding shares is at $35.4 million. </li>
<li>Nukkleus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) stock fell 10.64% to $16.09. The company's market cap stands at $84.8 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBAI

BTCS

CISO

ETWO

MLGO

NUKK

NVTS

RCAT

VUZI

12 Information Technology Stocks Moving In Tuesday's Intraday Session

Rumors

REKR

Watching Rekor Systems; Traders Circulate Popular Newsletter Buys Stock

iShares Trust Dow Jones US Industrial Sector Index Fund

KNSL

URBN

CNBC Halftime Report Final Trades: Kinsale Capital Group, Westinghouse Air Brake Technologies, iShares U.S. Industrials ETF, Urban Outfitters

Financial giants have made a conspicuous bullish move on Starbucks. Our analysis of options history for Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) revealed 18 unusual trades.
Delving into the details, we found 44% of traders were bullish, while 27% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $1,146,360, and 11 were calls, valued at $2,506,807.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $50.0 to $110.0 for Starbucks over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Starbucks's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Starbucks's whale trades within a strike price range from $50.0 to $110.0 in the last 30 days. 
<h3>Starbucks Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748365239_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$18.2</td>
<td>$17.65</td>
<td>$18.2</td>
<td>$80.00</td>
<td>$2.0M</td>
<td>914</td>
<td>372</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$3.65</td>
<td>$3.55</td>
<td>$3.58</td>
<td>$80.00</td>
<td>$716.0K</td>
<td>5.7K</td>
<td>2.0K</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/17/25</td>
<td>$11.8</td>
<td>$11.6</td>
<td>$11.7</td>
<td>$95.00</td>
<td>$117.0K</td>
<td>198</td>
<td>213</td>
</tr>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$4.65</td>
<td>$4.6</td>
<td>$4.6</td>
<td>$90.00</td>
<td>$107.6K</td>
<td>791</td>
<td>706</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$7.35</td>
<td>$7.3</td>
<td>$7.35</td>
<td>$90.00</td>
<td>$94.0K</td>
<td>165</td>
<td>193</td>
</tr>
</tbody>
</table>

<h3>About Starbucks</h3>
Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 40,000 stores across more than 80 countries as of the end of fiscal 2024. The firm operates in three segments: North America, international markets, and channel development (grocery and ready-to-drink beverage). The coffee chain generates revenue from company-operated stores, royalties, sales of equipment and products to license partners, ready-to-drink beverages, packaged coffee sales, and single-serve products.
Having examined the options trading patterns of Starbucks, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Starbucks</h3>
<ul>
<li>With a trading volume of 5,566,772, the price of SBUX is up by 2.95%, reaching $86.89.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 63 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Starbucks</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $92.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Starbucks, which currently sits at a price target of $100. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Starbucks, which currently sits at a price target of $98. 
&#x2A; Consistent in their evaluation, an analyst from Guggenheim keeps a Neutral rating on Starbucks with a target price of $79. 
&#x2A; Consistent in their evaluation, an analyst from Stifel keeps a Buy rating on Starbucks with a target price of $92. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Starbucks with a target price of $95. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Starbucks, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

SBUX

Check Out What Whales Are Doing With SBUX

Photronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAB#NASDAQ">PLAB</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-05-28. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Photronics will report an earnings per share (EPS) of $0.48.
The market awaits Photronics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company beat EPS by $0.05, leading to a 2.44% drop in the share price the following trading session.
Here's a look at Photronics's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.47</td>
<td>0.52</td>
<td>0.56</td>
<td>0.55</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.52</td>
<td>0.59</td>
<td>0.51</td>
<td>0.46</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>-6.0%</td>
<td>4.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1748365239_0_0.png" alt="eps graph" />
<h3>Photronics Share Price Analysis</h3>
Shares of Photronics were trading at $19.47 as of May 26. Over the last 52-week period, shares are down 24.85%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/PLAB/earnings">To track all earnings releases for Photronics visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PLAB

Earnings Preview For Photronics

Investors with a lot of money to spend have taken a bullish stance on Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CVNA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 61 uncommon options trades for Carvana.
This isn't normal.
The overall sentiment of these big-money traders is split between 60% bullish and 22%, bearish.
Out of all of the special options we uncovered, 29 are puts, for a total amount of $1,748,690, and 32 are calls, for a total amount of $2,197,642.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $150.0 and $460.0 for Carvana, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Carvana's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Carvana's substantial trades, within a strike price spectrum from $150.0 to $460.0 over the preceding 30 days.
<h3>Carvana Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748365234_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/13/25</td>
<td>$11.6</td>
<td>$9.45</td>
<td>$10.5</td>
<td>$320.00</td>
<td>$690.6K</td>
<td>155</td>
<td align="right">791</td>
</tr>
<tr>
<td>CVNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$16.15</td>
<td>$16.0</td>
<td>$16.0</td>
<td>$200.00</td>
<td>$320.0K</td>
<td>1.7K</td>
<td align="right">211</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$18.0</td>
<td>$17.95</td>
<td>$18.0</td>
<td>$390.00</td>
<td>$160.2K</td>
<td>237</td>
<td align="right">10</td>
</tr>
<tr>
<td>CVNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/21/25</td>
<td>$81.65</td>
<td>$80.75</td>
<td>$81.65</td>
<td>$360.00</td>
<td>$146.9K</td>
<td>200</td>
<td align="right">18</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$21.85</td>
<td>$20.65</td>
<td>$21.08</td>
<td>$302.50</td>
<td>$105.4K</td>
<td>92</td>
<td align="right">50</td>
</tr>
</tbody>
</table>

<h3>About Carvana</h3>
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.
Following our analysis of the options activities associated with Carvana, we pivot to a closer look at the company's own performance.
<h3>Where Is Carvana Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,572,073, with CVNA's price up by 2.74%, positioned at $312.43.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 64 days.</li>
</ul>
<h3>Expert Opinions on Carvana</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $320.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Carvana, targeting a price of $290. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Carvana, which currently sits at a price target of $290. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Carvana with a target price of $340. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Carvana with a target price of $340. 
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $340. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Carvana with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

CVNA

Market Whales and Their Recent Bets on CVNA Options

Applied Digital's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NYSE">APLD</a>) short percent of float has fallen 3.14% since its last report. The company recently reported that it has 62.63 million shares sold short, which is 30.54% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.73 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Applied Digital Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748365229_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Applied Digital has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Applied Digital's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Applied Digital's peer group average for short interest as a percentage of float is 6.43%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

APLD

What's Driving the Market Sentiment Around Applied Digital?

UBS analyst Joshua Chan maintains Korn Ferry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFY#NYSE">KFY</a>) with a Neutral and lowers the price target from $75 to $74.

UBS Maintains Neutral on Korn Ferry, Lowers Price Target to $74

Financial giants have made a conspicuous bullish move on Microchip Technology. Our analysis of options history for Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) revealed 17 unusual trades.
Delving into the details, we found 47% of traders were bullish, while 41% showed bearish tendencies. Out of all the trades we spotted, 12 were puts, with a value of $681,084, and 5 were calls, valued at $281,540.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $45.0 to $85.0 for Microchip Technology over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Microchip Technology stands at 708.4, with a total volume reaching 3,595.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Microchip Technology, situated within the strike price corridor from $45.0 to $85.0, throughout the last 30 days.
<h3>Microchip Technology 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748365229_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MCHP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$14.4</td>
<td>$13.9</td>
<td>$13.9</td>
<td>$65.00</td>
<td>$120.9K</td>
<td>0</td>
<td align="right">87</td>
</tr>
<tr>
<td>MCHP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/18/26</td>
<td>$4.5</td>
<td>$4.1</td>
<td>$4.1</td>
<td>$85.00</td>
<td>$82.0K</td>
<td>0</td>
<td align="right">200</td>
</tr>
<tr>
<td>MCHP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$3.5</td>
<td>$3.4</td>
<td>$3.5</td>
<td>$55.00</td>
<td>$70.0K</td>
<td>1.0K</td>
<td align="right">720</td>
</tr>
<tr>
<td>MCHP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$3.5</td>
<td>$3.4</td>
<td>$3.5</td>
<td>$55.00</td>
<td>$70.0K</td>
<td>1.0K</td>
<td align="right">520</td>
</tr>
<tr>
<td>MCHP</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$3.6</td>
<td>$3.4</td>
<td>$3.5</td>
<td>$55.00</td>
<td>$70.0K</td>
<td>1.0K</td>
<td align="right">200</td>
</tr>
</tbody>
</table>

<h3>About Microchip Technology</h3>
Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
After a thorough review of the options trading surrounding Microchip Technology, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Microchip Technology</h3>
<ul>
<li>With a trading volume of 3,819,520, the price of MCHP is up by 5.23%, reaching $59.13.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 65 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Microchip Technology</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $58.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Raymond James has revised its rating downward to Strong Buy, adjusting the price target to $65. 
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $66. 
&#x2A; An analyst from Citigroup persists with their Buy rating on Microchip Technology, maintaining a target price of $55. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Microchip Technology, which currently sits at a price target of $55. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Microchip Technology, which currently sits at a price target of $50. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Microchip Technology, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

MCHP

Unpacking the Latest Options Trading Trends in Microchip Technology

Regency Centers's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REG#NYSE">REG</a>) short percent of float has risen 9.72% since its last report. The company recently reported that it has 6.17 million shares sold short, which is 4.74% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.41 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Regency Centers Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748365224_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Regency Centers has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Regency Centers's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Regency Centers's peer group average for short interest as a percentage of float is 5.96%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Do Investors Really Feel About Regency Centers?

WR Berkley's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) short percent of float has fallen 11.19% since its last report. The company recently reported that it has 3.80 million shares sold short, which is 1.27% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.94 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>WR Berkley Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748365219_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for WR Berkley has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing WR Berkley's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, WR Berkley's peer group average for short interest as a percentage of float is 2.50%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What's Driving the Market Sentiment Around WR Berkley?

In the current session, the stock is trading at $146.69, after a 1.48% increase. Over the past month, Ensign Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) stock increased by 15.15%, and in the past year, by 26.36%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1748365218_0.png" alt="Past Year Chart" />

<h3>How Does Ensign Group P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of 16.33 in the Health Care Providers &amp; Services industry, Ensign Group Inc. has a higher P/E ratio of 27.27. Shareholders might be inclined to think that Ensign Group Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748365218_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

ENSG

Price Over Earnings Overview: Ensign Group

Health Care

Press Releases

Arcutis to Present at the 24th Annual Needham Virtual Healthcare Conference

Legal

Arcutis and Padagis Agree to Stay Patent Lawsuit

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Management

Arcutis Announces Chief Financial Officer Transition

Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update

Arcutis Announces Publication of Positive Data from ARRECTOR Trial Evaluating ZORYVE® (roflumilast) Foam 0.3% in Individuals with Psoriasis in Journal of American Medical Association Dermatology

New Consensus Statements on Impact of Genital Psoriasis on Patients from Genital Psoriasis Wellness Consortium Published in Journal of the European Academy of Dermatology and Venereology Clinical Practice

General

Arcutis' ZORYVE® (roflumilast) Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older

Agios Pharmaceuticals, Inc. - Common Stock

Agios Pharmaceuticals

Beam Therapeutics

Biohaven

CG Oncology

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Centessa Pharmaceuticals plc - American Depositary Shares

Centessa Pharmaceuticals

Denali Therapeutics

Dyne Therapeutics

89bio

Amicus Therapeutics

Galapagos NV - American Depositary Shares

Galapagos

GRAIL

IDEAYA Biosciences

Immunocore Holdings plc - American Depositary Shares

Immunocore Holdings

Disc Medicine

Janux Therapeutics

Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares

Kiniksa Pharmaceuticals

Kymera Therapeutics

Mesoblast Limited - American Depositary Shares

Mesoblast

NewAmsterdam Pharma Company N.V. - Ordinary Shares

NewAmsterdam Pharma Co

Recursion Pharmaceuticals, Inc. - Class A Common Stock

Recursion Pharmaceuticals

ARS Pharmaceuticals

Travere Therapeutics, Inc. - Common Stock

Travere Therapeutics

Twist Bioscience Corporation - Common Stock

Twist Bioscience

Vericel

Needham

HC Wainwright & Co.

Jefferies

Goldman Sachs

Mizuho

지난 일주일 동안 가장 실적이 좋았던 중형주 10개 종목은 다음과 같다.
<ol>
<li>디지넥스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>): 주가가 108.29% 급등했다. 이는 투자자 불확실성 및 여러 리스크 요인으로 인해 지난주 시장이 조정 국면에 들어간 후 전반적인 반등이 있었기 때문일 가능성이 높다.</li>
<li>넥스트데케이드 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXT#NASDAQ">NEXT</a>): 주가가 25.07% 상승했다. 미국 D.C. 항소법원이 2024년 8월 판결에 대한 수정을 발표하여 연방 에너지 규제 위원회의 명령에 대한 무효화 위험을 제거했다.</li>
<li>셀시우스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>): 주가가 21.60% 상승했다. 이는 펩시코(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>)가 프리바이오틱 <a href="https://www.benzinga.com//node/44360669" target="_blank" rel="noreferrer noopener">소다 브랜드 팝피(Poppi)를 19억 5천만 달러에 인수한다는 소식</a>에 반응했을 가능성이 높다.</li>
<li>시그넷 주얼러스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>): 주가가 21.08% 상승했다. 이는 2025회계연도 4분기 실적을 발표하고 여러 애널리스트가 <a href="https://www.benzinga.com//node/44423649" target="_blank" rel="noreferrer noopener">주가 전망을 수정한</a> 후 발생한 일이다.</li>
<li>뉴 포트리스 에너지 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>): 주가가 20.63% 상승했다. 이는 달러 약세와 미국의 후티 공격 목표에 대한 공습으로 인한 영향, 그리고 강한 중국 경제 데이터가 수요 전망을 끌어올렸기 때문이다.</li>
<li>밀로즈 프로퍼티스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRP#NYSE">MRP</a>): 주가가 16.61% 상승했다. 이러한 급등은 회사가 첫 배당금을 선언하고 <a href="https://www.benzinga.com//node/44365712" target="_blank" rel="noreferrer noopener">2025년 전망을 발표</a>한 이후 발생했다.</li>
<li>아커티스 바이오테라퓨틱스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQT#NASDAQ">ARQT</a>): 주가가 16.35% 상승했다. 이는 캐나다 보건부가 아토피성 피부염 치료를 위한 조리브(Zoryve) 크림을 승인한 후 발생한 일이다.</li>
<li>루시드 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>): 주가가 15.79% 상승했다. 이는 모건스탠리가 주식을 <a href="https://www.benzinga.com//node/44373086" target="_blank" rel="noreferrer noopener">비중축소에서 중립으로 상향 조정</a>한 이후 발생한 일이다.</li>
<li>캐털리스트 파마슈티컬스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRX#NASDAQ">CPRX</a>): 주가가 15.27% 상승했다.</li>
<li>스톤코 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>): 주가가 14.20% 상승했다. 이는 회사가 4분기 EPS 및 매출이 예상보다 좋게 나타났다고 발표한 후 나타났다.</li>
</ol>
사진 출처: Around the World Photos, Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Arcutis Biotherapeutics

뉴스

에 대한 최신 뉴스 Arcutis Biotherapeutics (NASDAQ:ARQT) 주식

일요일, 3월 23, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌